)
P3 Health Partners (PIII) investor relations material
P3 Health Partners Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Transitional year marked by operational discipline, network and payer rationalization, and expansion of the Care Enablement Model, with a focus on stability and maturing clinical foundation.
Operates a physician-led population health management platform focused on Medicare Advantage, serving approximately 116,000 at-risk members across 24 markets in four states as of September 30, 2025.
Revenue is highly predictable due to recurring capitation contracts, but profitability is challenged by high medical costs and ongoing net losses.
Strategic initiatives include provider network rationalization, joint ventures to add ACO members, and a $120–$170 million EBITDA expansion opportunity targeting profitability in 2026.
Management is focused on growing MA membership, expanding into new markets, and improving medical cost management and operating efficiencies.
Financial highlights
Q3 2025 operating revenue was $345.3 million, down 5% year-over-year, primarily due to a 10% decrease in average at-risk members from strategic contract terminations.
Q3 adjusted EBITDA loss was $45.9 million; year-to-date normalized adjusted EBITDA loss was $70.1 million.
Net loss for Q3 2025 was $69.5 million, an improvement from $102.9 million in Q3 2024.
Medical margin for Q3 2025 was $4.4 million ($13 PMPM), up from $0.5 million ($1 PMPM) in the prior year.
Operating expense for Q3 2025 was $21.1 million, down 33% from $31.6 million in the prior year period.
Cash and restricted cash at September 30, 2025, totaled $38.5 million.
Outlook and guidance
Full-year 2025 revenue guidance is $1.4 to $1.45 billion, with medical margin expected between $67 and $82 million.
Adjusted EBITDA loss for 2025 is forecasted between $95 and $110 million.
Management expects continued net losses and negative cash flows in the near term, with substantial doubt about the ability to continue as a going concern without additional capital.
$120 million–$170 million in EBITDA expansion opportunities identified for the next five quarters, with line of sight to profitability in 2026.
Expecting 5% base rate improvement in premium for 2026, with further upside from coding improvements.
Next P3 Health Partners earnings date
Next P3 Health Partners earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage